Timing: Evening administration preferred
Induction of erythropoiesis in anemic patients by prolylhydroxylase inhibitor in a repeat dose, randomized placebo controlled trial [abstract]
The peptide has to penetrate the outer skin barrier (stratum corneum), which limits how much active compound reaches the deeper dermal layers where collagen and elastin are produced
(28) The crude incidence rates of LLA were 6.1 per 10,000 person-years for GLP-1 receptor agonists, 1.5 for SGLT-2 inhibitors, 4.6 for DPP-4 inhibitors, and 1.9 for older agents
Most users report skin appearing essentially unchanged during this initial two-week window, creating false security that benefits will maintain indefinitely without recognizing that collagen degradation processes haven't yet depleted treatment-induced gains
Every batch is tested by independent EU laboratories using HPLC for purity verification and mass spectrometry for sequence confirmation